V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003476 | 210014035 | 1.57 | 69.7 | Neo-adjuvant (N) | null | 2020-04-20 | ROSCO Trial | 02 | N | CARBOPLATIN + DOCETAXEL | 100010778 |
| 210003548 | 210014036 | 1.59 | 109.2 | null | 2019-10-15 | 2020-01-25 | Neratinib | 02 | null | NERATINIB | 100525179 |
| 210003725 | 210014037 | 1.65 | 81.6 | Palliative (P) | 2022-02-02 | 2022-02-10 | null | 02 | N | PALBOCICLIB | 100388097 |
| 210000062 | 210014054 | 1.67 | null | Adjuvant (A) | null | 2020-08-01 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100225173 |
| 210001109 | 210014058 | null | null | Palliative (P) | 2019-09-04 | 2019-10-09 | null | N | N | LETROZOLE + PALBOCICLIB | 100904517 |
| 210001994 | 210014061 | 1.6 | 77 | Adjuvant (A) | null | 2020-03-30 | Capecitabine | 02 | N | CAPECITABINE | 100155303 |
| 210002127 | 210014062 | 1.51 | 92.2 | null | null | 2022-01-04 | Neratinib | 02 | null | NERATINIB | 100657281 |
| 210003226 | 210014063 | 1.72 | 104.6 | Adjuvant (A) | 2020-09-25 | 2020-12-11 | CARBOPLATIN | 02 | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100456723 |
| 210003226 | 210014082 | 1.56 | 76.6 | null | 2020-12-23 | 2021-01-01 | Capecitabine | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100456723 |
| 210003324 | 210014083 | 1.59 | 89.4 | null | 2022-04-25 | 2022-04-29 | PERTUZUMAB + TRASTUZUMAB | 02 | null | PERTUZUMAB + TRASTUZUMAB | 100837867 |
| 210003466 | 210014084 | 1.67 | 51 | Neo-adjuvant (N) | 2022-03-17 | 2022-03-31 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100042368 |
| 210003476 | 210014085 | null | 72 | null | 2016-02-19 | 2020-04-15 | CARBOPLATIN | null | null | CARBOPLATIN | 100010778 |
| 210003725 | 210014086 | null | null | null | 2022-03-15 | 2022-03-29 | FEC 100 | 02 | null | ABEMACICLIB + FULVESTRANT | 100388097 |
| 210003226 | 210014096 | 1.66 | 82 | Neo-adjuvant (N) | null | 2021-01-01 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100456723 |
| 210003324 | 210014097 | 1.68 | 55.2 | Curative (C) | null | 2022-04-29 | Docetaxel 75mg/m2 (21 day) | null | null | DOCETAXEL | 100837867 |
| 210003466 | 210014098 | 1.61 | 55 | null | 2022-04-02 | 2022-04-09 | Capecitabine | 02 | null | CAPECITABINE | 100042368 |
| 210003725 | 210014100 | 1.7 | 0 | Palliative (P) | 2022-04-14 | 2022-04-28 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100388097 |
| 210003725 | 210014108 | 1.5 | 107 | Palliative (P) | null | 2022-05-26 | Carboplatin AUC 2 - 5 | 01 | N | CARBOPLATIN | 100388097 |
| 210003226 | 210014113 | 1.54 | 98 | Curative (C) | null | 2021-02-16 | Docetaxel | 02 | null | DOCETAXEL | 100456723 |
| 210003226 | 210014122 | 1.54 | 55.1 | Adjuvant (A) | 2020-12-10 | 2021-02-20 | null | null | N | PACLITAXEL + PERTUZUMAB + TRASTUZUMAB | 100456723 |
| 210003226 | 210014124 | 1.68 | 71.5 | null | null | 2021-03-19 | Epirubicin (weekly) | 02 | null | FEC | 100456723 |
| 210003226 | 210014126 | 1.59 | 108 | null | 2021-03-12 | 2021-03-25 | null | 02 | null | EPIRUBICIN | 100456723 |
| 220000031 | 220000031 | null | null | null | null | 2017-11-19 | null | null | null | CNS EPENDYMOMA II VINC/CARBO + VALPROATE | 101646338 |
| 220000071 | 220000071 | null | null | null | null | 2018-04-27 | Temozolomide 150mg/m2 | 02 | null | TEMOZOLOMIDE | 100633413 |
| 220000124 | 220000124 | null | null | null | null | 2016-08-15 | Ipilimumab | 02 | null | TEMOZOLOMIDE | 101269526 |
| 220000155 | 220000155 | null | null | null | null | 2018-11-28 | null | 02 | null | TEMOZOLOMIDE + RT | 100377868 |
| 220000167 | 220000167 | null | null | null | null | 2020-04-05 | null | 02 | null | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100522851 |
| 220000173 | 220000173 | null | null | null | null | 2018-09-05 | null | null | null | TEMOZOLOMIDE | 100276779 |
| 220000179 | 220000179 | null | null | null | null | 2017-12-21 | null | null | null | PEMBROLIZUMAB | 100913650 |
| 220000190 | 220000190 | null | null | null | null | 2017-04-19 | null | null | null | TEMOZOLOMIDE | 101554333 |
| 220000227 | 220000227 | null | null | null | null | 2017-11-11 | null | null | null | TEMOZOLOMIDE | 101477523 |
| 220000272 | 220000272 | null | null | null | null | 2019-06-06 | null | null | null | TEMOZOLOMIDE | 100179628 |
| 220000289 | 220000289 | null | null | null | null | 2019-02-27 | null | null | null | TEMOZOLOMIDE + RT | 100747165 |
| 220000307 | 220000307 | null | null | null | null | 2016-10-28 | null | 02 | null | TEMOZOLOMIDE | 100642610 |
| 220000321 | 220000321 | null | null | null | null | 2017-12-01 | CNS HGG Temozolomide +XRT | null | null | CNS MEDBL HR POG 9031 VINC/CYCLOPHOS | 100184742 |
| 220000361 | 220000361 | null | null | null | null | 2018-01-25 | null | 02 | null | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100592039 |
| 220000365 | 220000365 | null | null | null | null | 2018-05-04 | null | null | null | TEMOZOLOMIDE | 101421297 |
| 220000374 | 220000374 | null | null | null | null | 2017-07-23 | null | 02 | null | TEMOZOLOMIDE | 100976252 |
| 220000395 | 220000395 | null | null | null | null | 2017-02-15 | null | 02 | null | VINBLASTINE | 100806645 |
| 220000431 | 220000431 | null | null | null | null | 2016-09-03 | TEMOZOLOMIDE | null | null | TEMOZOLOMIDE | 101720730 |
| 220000443 | 220000443 | null | null | null | null | 2017-12-29 | null | 02 | null | TEMOZOLOMIDE + RT | 100640392 |
| 220000474 | 220000474 | null | null | null | null | 2016-10-27 | Temozolomide + RT | 02 | null | TEMOZOLOMIDE | 100161863 |
| 220000504 | 220000504 | null | null | null | null | 2018-06-01 | Temozolomide + RT | null | null | TEMOZOLOMIDE + RT | 100357106 |
| 220000531 | 220000531 | null | null | null | null | 2019-05-29 | null | null | null | TEMOZOLOMIDE | 100845508 |
| 220000548 | 220000548 | null | null | null | null | 2017-12-08 | null | null | null | TEMOZOLOMIDE + RT | 100883496 |
| 220000554 | 220000554 | null | null | null | null | 2018-02-21 | null | null | null | CNS HGG TEMOZOLOMIDE +XRT | 101614434 |
| 220000570 | 220000570 | null | null | null | null | 2018-12-11 | null | null | null | TEMOZOLOMIDE | 100963687 |
| 220000582 | 220000582 | null | null | null | null | 2017-04-30 | Temozolomide 150mg/m2 | null | null | TEMOZOLOMIDE | 100867772 |
| 220000617 | 220000617 | null | null | null | null | 2016-12-17 | Lomustine | null | null | TEMOZOLOMIDE | 101114256 |
| 220000637 | 220000637 | null | null | null | null | 2016-03-08 | null | null | null | TEMOZOLOMIDE | 101481622 |